Stock News

Ares Dynamic Credit Allocation Fund, Inc. Announces Distribution for November 2024 Details of the Distribution: Ex-Date: November 21, 2024 Record Date: November 21, 2024 Payable Date: November 29, 2024 Per Share Amount: $0.1175 The Ares Dynamic Credit Allocation Fund, Inc. (NYSE:ARDC) has declared a distribution for the month of November 2024. Shareholders will receive $0.1175…

Angi Inc. Posts Strong Third Quarter Financial Results Denver, Nov. 11, 2024 (GLOBE NEWSWIRE) — Angi Inc. (NASDAQ: ANGI) reported its third quarter financial results today. The company’s earnings beat analysts’ expectations, highlighting its continued growth and success in the home services industry. Investors can access the full report on the investor relations section of…

Investors Beware: Losses in Elanco Could Cost You By: The Financial Guru When it comes to investing, it’s important to always keep a keen eye on your portfolio. And if you’ve suffered losses exceeding $100,000 in Elanco between November 7, 2023 and June 26, 2024, well, you may want to pay especially close attention. Faruqi…

What’s Really Going on with Assertio Holdings, Inc.? The Buxton Helmsley Group, Inc. Speaks Out Fraud at Spectrum Pharmaceuticals, Inc. So, you may have heard about the recent drama surrounding Assertio Holdings, Inc. Well, let me break it down for you in true gossip column style. The Buxton Helmsley Group, Inc., a fancy investment fund…

Welcome to the Future of Financial Consulting A Game-Changing Acquisition in the Life Sciences Industry It’s a brisk fall day in Beverly Hills, California, and the atmosphere is abuzz with excitement as Nordicus Partners Corporation makes a groundbreaking announcement. The financial consulting company, known for its expertise in assisting Nordic and U.S. life sciences companies…

JTAI Announces Reverse Stock Split Las Vegas, NV, Nov. 11, 2024 (GLOBE NEWSWIRE) Jet.AI Inc. (Nasdaq: JTAI) has made a significant announcement today regarding a reverse stock split of its outstanding shares of common stock. The Company will be implementing a reverse stock split at a ratio of 1-for-225. This strategic move is poised to…

Iovance Biotherapeutics Q3 Earnings Review Introduction Iovance Biotherapeutics recently announced their Q3 earnings, which outperformed expectations with $58.6 million in revenue. Despite this positive news, the company’s shares fell due to high market expectations and concerns about competition in the industry. Overview of Amtagvi Amtagvi, Iovance’s lead drug, has shown strong commercial potential. The company…

Robbins Geller Rudman & Dowd LLP Announces Deadline for Lead Plaintiff Motion in Acadia Healthcare Company, Inc. Class Action Lawsuit Overview SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) — The prestigious law firm of Robbins Geller Rudman & Dowd LLP has issued a statement informing purchasers or acquirers of Acadia Healthcare Company, Inc. publicly traded…